WHO Drug Dictionary
• A source of international drug names • Substance names according to International Non Proprietary Names (INN) ... – Nonproprietary names • Multiple ingredient drugs – Trade names • First reported brand of a given ingredient combination – Nonproprietary names Magnus Wallberg, UMC.
Download WHO Drug Dictionary
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
The Object-Oriented
coddyschool.comContents v Contents at a Glance Introduction 1 1 Introduction to Object-Oriented Concepts5 2 How to Think in Terms of Objects 37 3 Advanced Object-Oriented Concepts 53 4 The Anatomy of a Class 75 5 Class Design Guidelines 87 6 Designing with Objects 103 7 Mastering Inheritance and Composition129 8 Frameworks and Reuse: Designing with Interfaces and Abstract …
ICD–11 Fact Sheet
icd.who.int2 WHO International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognised and is public property. A nonproprietary name is also known as a generic name.
Drug Fact Sheet: Marijuana/Cannabis - DEA
www.dea.govthe generic or International Nonproprietary Name given to THC), prescribed for the control of nausea and vomiting caused by chemotherapeutic agents used in the treatment of cancer and to stimulate appetite in acquired immune deficiency syndrome (AIDS) patients. Marinol is a Schedule III drug under the Controlled Substances Act.
A/E/C Computer-Aided Design (CAD) Standard
www.wbdg.orgnonproprietary CAD standard that incorporates existing industry, national, and international standards and to develop data standards that ... Citation of trade names does not constitute an official endorsement or approval of the use of such commercial products.
Revised monoclonal antibody (mAb) nomenclature scheme ...
www.who.intInternational Nonproprietary Names Programme 1 Revised monoclonal antibody (mAb) nomenclature scheme International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property.